Trevena, Inc. (Nasdaq: NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders,...
Trevena, Inc. (Nasdaq: NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders,...
Trevena (TRVN) Halted Again on Volatility, Up 127%Earlier Announces Approval of OLINVYK in China
Trevena (NASDAQ:TRVN), Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS)...
New York, USA, May 02, 2023 (GLOBE NEWSWIRE) -- Acute Heart Failure Market to Witness Upsurge in Growth, Examine DelveInsight | Key Companies in the Domain - AstraZeneca, Boehringer...
Trevena, Inc. (Nasdaq: NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders,...
Trevena, Inc. (Nasdaq: NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders,...
Investing.com - Trevena Inc reported on Wednesday third quarter {{erl-100177||earnings that beat analysts' forecasts and revenue that fell short of expectations. Trevena Inc announced...
Trevena (TRVN) reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $-440000000000 versus the consensus estimate of $543.75...
Trevena (NASDAQ:TRVN) reported Q2 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10).
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Healthcare and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Technology, Telecoms and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Technology, Healthcare and Utilities sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Technology, Healthcare and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Oil & Gas, Utilities and Healthcare sectors propelled shares higher while losses in the Basic Materials,...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Utilities, Consumer Goods and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
